Literature DB >> 11359760

Acute myocardial infarction: primary angioplasty.

F Zijlstra1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11359760      PMCID： PMC1729777          DOI： 10.1136/heart.85.6.705

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  15 in total

Review 1.  Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra
Journal:  Eur Heart J       Date:  2000-09       Impact factor: 29.983

2.  The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.

Authors:  J G Canto; N R Every; D J Magid; W J Rogers; J A Malmgren; P D Frederick; W J French; A J Tiefenbrunn; V K Misra; C I Kiefe; H V Barron
Journal:  N Engl J Med       Date:  2000-05-25       Impact factor: 91.245

3.  Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction.

Authors:  C L Grines; D L Marsalese; B Brodie; J Griffin; B Donohue; C R Costantini; C Balestrini; G Stone; T Wharton; P Esente; M Spain; J Moses; M Nobuyoshi; M Ayres; D Jones; D Mason; D Sachs; L L Grines; W O'Neill
Journal:  J Am Coll Cardiol       Date:  1998-04       Impact factor: 24.094

4.  Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction.

Authors:  F Zijlstra; J C Hoorntje; M J de Boer; S Reiffers; K Miedema; J P Ottervanger; A W van 't Hof; H Suryapranata
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

5.  Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study.

Authors:  L F van den Merkhof; F Zijlstra; H Olsson; L Grip; G Veen; F W Bär; M J van den Brand; M L Simoons; F W Verheugt
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

6.  High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial.

Authors:  A Liem; F Zijlstra; J P Ottervanger; J C Hoorntje; H Suryapranata; M J de Boer; F W Verheugt
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

7.  Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study.

Authors:  P Widimský; L Groch; M Zelízko; M Aschermann; F Bednár; H Suryapranata
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

8.  Projected cost-effectiveness of primary angioplasty for acute myocardial infarction.

Authors:  T A Lieu; R J Gurley; R J Lundstrom; G T Ray; B H Fireman; M C Weinstein; W W Parmley
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

9.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

10.  Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; D A Cox; G W Stone; E Garcia; L A Mattos; A Giambartolomei; B R Brodie; O Madonna; M Eijgelshoven; A J Lansky; W W O'Neill; M C Morice
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245
View more
  2 in total

Review 1.  Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis.

Authors:  Christian Asseburg; Yolanda Bravo Vergel; Stephen Palmer; Elisabeth Fenwick; Mark de Belder; Keith R Abrams; Mark Sculpher
Journal:  Heart       Date:  2007-02-03       Impact factor: 5.994

2.  No-Reflow after PPCI-A Predictor of Short-Term Outcomes in STEMI Patients.

Authors:  Larisa Renata Pantea-Roșan; Vlad Alin Pantea; Simona Bungau; Delia Mirela Tit; Tapan Behl; Cosmin Mihai Vesa; Cristiana Bustea; Radu Dumitru Moleriu; Marius Rus; Mircea Ioachim Popescu; Vladiana Turi; Camelia Cristina Diaconu
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.